193 related articles for article (PubMed ID: 29244729)
1. Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: In Vitro Cellular Uptake.
Wu M; Sun D; Tyner K; Jiang W; Rouse R
Nanomaterials (Basel); 2017 Dec; 7(12):. PubMed ID: 29244729
[TBL] [Abstract][Full Text] [Related]
2. Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: Physicochemical Characterization.
Sun D; Rouse R; Patel V; Wu Y; Zheng J; Karmakar A; Patri AK; Chitranshi P; Keire D; Ma J; Jiang W
Nanomaterials (Basel); 2018 Jan; 8(1):. PubMed ID: 29303999
[TBL] [Abstract][Full Text] [Related]
3. Sodium ferric gluconate (SFG) in complex with sucrose for IV infusion: bioequivalence of a new generic product with the branded product in healthy volunteers.
Baribeault D
Curr Med Res Opin; 2011 Aug; 27(8):1653-7. PubMed ID: 21714710
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Physicochemical Properties of the Iron Nanoparticle Drug Products: Brand and Generic Sodium Ferric Gluconate.
Brandis JEP; Kihn KC; Taraban MB; Schnorr J; Confer AM; Batelu S; Sun D; Rodriguez JD; Jiang W; Goldberg DP; Langguth P; Stemmler TL; Yu YB; Kane MA; Polli JE; Michel SLJ
Mol Pharm; 2021 Apr; 18(4):1544-1557. PubMed ID: 33621099
[TBL] [Abstract][Full Text] [Related]
5. Comparative Evaluation of U.S. Brand and Generic Intravenous Sodium Ferric Gluconate Complex in Sucrose Injection: Biodistribution after Intravenous Dosing in Rats.
Beekman CR; Matta M; Thomas CD; Mohammad A; Stewart S; Xu L; Chockalingam A; Shea K; Sun D; Jiang W; Patel V; Rouse R
Nanomaterials (Basel); 2017 Dec; 8(1):. PubMed ID: 29283393
[TBL] [Abstract][Full Text] [Related]
6. Short-term stability of a new generic sodium ferric gluconate in complex with sucrose.
Baribeault D
Curr Med Res Opin; 2011 Dec; 27(12):2241-3. PubMed ID: 21992082
[TBL] [Abstract][Full Text] [Related]
7. Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American Clinical Trial.
Nissenson AR; Lindsay RM; Swan S; Seligman P; Strobos J
Am J Kidney Dis; 1999 Mar; 33(3):471-82. PubMed ID: 10070911
[TBL] [Abstract][Full Text] [Related]
8. Sodium ferric gluconate complex in sucrose: safer intravenous iron therapy than iron dextrans.
Faich G; Strobos J
Am J Kidney Dis; 1999 Mar; 33(3):464-70. PubMed ID: 10070910
[TBL] [Abstract][Full Text] [Related]
9. A Comparative Look at the Safety Profiles of Intravenous Iron Products Used in the Hemodialysis Population.
Coppol E; Shelly J; Cheng S; Kaakeh Y; Shepler B
Ann Pharmacother; 2011 Feb; 45(2):241-7. PubMed ID: 21304025
[TBL] [Abstract][Full Text] [Related]
10. Safety of Intravenous Iron in Hemodialysis: Longer-term Comparisons of Iron Sucrose Versus Sodium Ferric Gluconate Complex.
Winkelmayer WC; Goldstein BA; Mitani AA; Ding VY; Airy M; Mandayam S; Chang TI; Brookhart MA; Fishbane S
Am J Kidney Dis; 2017 Jun; 69(6):771-779. PubMed ID: 28063734
[TBL] [Abstract][Full Text] [Related]
11. Iron management: innovative solutions to persistent challenges--focus on Ferrlecit.
Vogel S; Schweitzer S; Seiler S
ANNA J; 1999 Oct; 26(5):515-21. PubMed ID: 10776080
[TBL] [Abstract][Full Text] [Related]
12. Comparative Short-term Safety of Sodium Ferric Gluconate Versus Iron Sucrose in Hemodialysis Patients.
Brookhart MA; Freburger JK; Ellis AR; Winkelmayer WC; Wang L; Kshirsagar AV
Am J Kidney Dis; 2016 Jan; 67(1):119-27. PubMed ID: 26385819
[TBL] [Abstract][Full Text] [Related]
13. Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis.
Pai AB; Boyd AV; McQuade CR; Harford A; Norenberg JP; Zager PG
Pharmacotherapy; 2007 Mar; 27(3):343-50. PubMed ID: 17316146
[TBL] [Abstract][Full Text] [Related]
14. Intravenous iron replacement with sodium ferric gluconate complex in sucrose for iron deficiency anemia in adults.
Kane RC
Curr Ther Res Clin Exp; 2003 Apr; 64(4):263-8. PubMed ID: 24944373
[TBL] [Abstract][Full Text] [Related]
15. Snapshots of Iron Speciation: Tracking the Fate of Iron Nanoparticle Drugs via a Liquid Chromatography-Inductively Coupled Plasma-Mass Spectrometric Approach.
Neu HM; Alexishin SA; Brandis JEP; Williams AMC; Li W; Sun D; Zheng N; Jiang W; Zimrin A; Fink JC; Polli JE; Kane MA; Michel SLJ
Mol Pharm; 2019 Mar; 16(3):1272-1281. PubMed ID: 30676753
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications.
Jahn MR; Andreasen HB; Fütterer S; Nawroth T; Schünemann V; Kolb U; Hofmeister W; Muñoz M; Bock K; Meldal M; Langguth P
Eur J Pharm Biopharm; 2011 Aug; 78(3):480-91. PubMed ID: 21439379
[TBL] [Abstract][Full Text] [Related]
17. Modified Regulatory Pathways to Approve Generic Drugs in the US and a Systematic Review of Their Outcomes.
Kesselheim AS; Polinski JM; Fulchino LA; Isaman DL; Gagne JJ
Drugs; 2015 Apr; 75(6):633-50. PubMed ID: 25822610
[TBL] [Abstract][Full Text] [Related]
18. Sodium ferric gluconate therapy in renal transplant and renal failure patients.
Yorgin PD; Belson A; Sarwal M; Alexander SR
Pediatr Nephrol; 2000 Dec; 15(3-4):171-5. PubMed ID: 11149105
[TBL] [Abstract][Full Text] [Related]
19. Safe administration of iron sucrose in a patient with a previous hypersensitivity reaction to ferric gluconate.
Sane R; Baribeault D; Rosenberg CL
Pharmacotherapy; 2007 Apr; 27(4):613-5. PubMed ID: 17381390
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo DFO-chelatable labile iron release profiles among commercially available intravenous iron nanoparticle formulations.
Pai AB; Pai MP; Meyer DE; Bales BC; Cotero VE; Zheng N; Jiang W
Regul Toxicol Pharmacol; 2018 Aug; 97():17-23. PubMed ID: 29857115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
